NCT01469481View on ClinicalTrials.gov

Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Healthy
Interventions
DRUG

PF-04991532

a single oral dose of \[14C\]PF-04991532 (450 mg/100 uCi suspension)

Trial Locations (1)

98418

Pfizer Investigational Site, Tacoma

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01469481 - Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532 | Biotech Hunter | Biotech Hunter